AIML06 - A.I. in Healthcare: Medical Device Cybersecurity
Program Description
Missed the live webinar? Register for the online self-paced section. The program includes two hours of content, followed by a short assessment survey.
As healthcare becomes increasingly digitized, the integration of artificial intelligence (A.I.) into medical devices brings both groundbreaking innovation and unprecedented cybersecurity risks. This two-hour webinar explores how A.I. is transforming healthcare delivery through connected devices, and the critical security measures needed to protect patient safety and sensitive data.
Join experts from the fields of healthcare, A.I., and cybersecurity for an in-depth discussion on the vulnerabilities, regulatory frameworks, and mitigation strategies specific to A.I.-enabled medical devices. Discover how organizations can stay ahead of cyber threats while maximizing the benefits of A.I.-driven technologies in clinical settings.
Learning Objectives:
After completing the program, you will be able to:
- Identify common cybersecurity risks associated with AI-integrated medical devices
- Understand regulatory expectations (e.g., FDA premarket guidance on cybersecurity)
- Apply strategies to design, implement, and monitor secure medical devices
- Analyze case studies of A.I.-related vulnerabilities and response plans
- Prepare for emerging cybersecurity threats in digital healthcare systems
Who Should Attend:
- Biomedical engineers and medical device developers
- Healthcare IT and cybersecurity professionals
- Regulatory compliance officers
- A.I. and data science professionals working in healthcare
- Hospital administrators and clinical leadership
- Startups and innovators in medtech or health A.I.
Agenda:
Part 1: How AI enabled devices and products are built
Part 2: How AI enabled devices and products are managed within healthcare entities
Part 3: How is AI being used as a threat
Part 4: Panel Discussion and Q&A
Olga Imas, Ph.D., is the Director of Applied AI Education and a Professor of Biomedical Engineering at the Milwaukee School of Engineering (MSOE). She leads the integration of Applied AI into MSOE's educational practices and teaches courses on medical device regulation and standards, signals and systems, digital signal processing, medical imaging, and circuit theory. 
Samantha Jacques, PhD, FACHE, AAMIF, FACCE is the Vice President of Clinical Engineering at McLaren Health. She manages medical devices throughout the McLaren system including 13 hospitals, ambulatory surgery centers, imaging centers, and Michigan’s largest network of cancer centers. Prior to McLaren, she was Director of Clinical Engineering at Penn State Health and Texas Children’s Hospital. She is Vice Chair of the Health Sector Coordinating Council – Cybersecurity and sits on the Board of AAMI. She has also published a book titled “Introduction to Clinical Engineering” and adjunct teaches at several institutions in the field of cybersecurity. She has a BS in Biomedical Engineering from Milwaukee School of Engineering and a PhD in Biomedical Engineering from Louisiana Tech University.
With over two decades of experience at the intersection of information technology, cybersecurity, and sales in the life sciences and healthcare sectors, Kyle brings a unique and powerful blend of technical acumen and commercial strategy. He is a Certified Information Systems Security Professional (CISSP) and holds both a master’s degree in Electrical & Computer Engineering and a bachelor’s in Biomedical Engineering from the University of Iowa. Kyle has held senior leadership roles at renowned organizations including GE HealthCare and Roche, where he’s been instrumental in shaping cybersecurity strategies, driving sales growth, and managing large-scale digital transformation efforts.
Aaron Pritz is the CEO, Principal Consultant and Co-Founder and started Reveal Risk in 2018 to address a gap he and his partners observed over many years working with major consulting firms. 
Todd Wilkinson has spent more than 20 years shaping the pharmaceutical and life sciences industries through a variety of technical and leadership roles. He began his career in systems and network infrastructure, later expanding into building and manufacturing diagnostic and data products—all while developing security teams to protect and strengthen those offerings. Most recently, before joining Reveal Risk, Todd built Elanco Animal Health’s security program and guided the company through its IPO. He specializes in securing infrastructure, supporting product launches, and digging into large data sets to uncover those elusive needles in the haystack.